Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy: A Report of 2 Cases.

Navarrete-Dechent C, Cordova M, Postow MA, Pulitzer M, Lezcano C, Halpern AC, Rossi AM.

JAMA Dermatol. 2019 Mar 1;155(3):347-352. doi: 10.1001/jamadermatol.2018.3688.

PMID:
30624578
2.

Continuous Spatial Sequences of Lichen Sclerosus, Penile Intraepithelial Neoplasia, and Invasive Carcinomas: A Study of 109 Cases.

Cañete-Portillo S, Sanchez DF, Fernández-Nestosa MJ, Piris A, Zarza P, Oneto S, Gonzalez Stark L, Lezcano C, Ayala G, Rodriguez I, Hoang MP, Mihm MC, Cubilla AL.

Int J Surg Pathol. 2019 Aug;27(5):477-482. doi: 10.1177/1066896918820960. Epub 2019 Jan 7.

PMID:
30614356
3.

Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice.

Tsai JJ, Velardi E, Shono Y, Argyropoulos KV, Holland AM, Smith OM, Yim NL, Rao UK, Kreines FM, Lieberman SR, Young LF, Lazrak A, Youssef S, Fu YY, Liu C, Lezcano C, Murphy GF, Na IK, Jenq RR, Hanash AM, Dudakov JA, van den Brink MRM.

Blood. 2018 Dec 27;132(26):2763-2774. doi: 10.1182/blood-2017-10-812941. Epub 2018 Oct 31.

PMID:
30381375
4.

Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis.

Martins CO, Lezcano C, Yi SS, Landau HJ, Chapman JR, Dogan A.

Haematologica. 2018 Dec;103(12):e610-e612. doi: 10.3324/haematol.2018.203000. Epub 2018 Sep 27. No abstract available.

5.

PRAME Expression in Melanocytic Tumors.

Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ.

Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134.

6.

Solitary fibrous tumor presenting on the scalp: a potential diagnostic pitfall.

Mori S, Lezcano C, Miraflor AP, Busam KJ, Lee EH.

J Cutan Pathol. 2018 Aug;45(8):557-560. doi: 10.1111/cup.13272. No abstract available.

7.

Primary and Metastatic Melanoma With NTRK Fusions.

Lezcano C, Shoushtari AN, Ariyan C, Hollmann TJ, Busam KJ.

Am J Surg Pathol. 2018 Aug;42(8):1052-1058. doi: 10.1097/PAS.0000000000001070.

8.

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Rabinowits G, Lezcano C, Catalano PJ, McHugh P, Becker H, Reilly MM, Huang J, Tyagi A, Thakuria M, Bresler SC, Sholl LM, Shapiro GI, Haddad R, DeCaprio JA.

Oncologist. 2018 Jul;23(7):814-821. doi: 10.1634/theoncologist.2017-0552. Epub 2018 Feb 14.

9.

Polyarthralgias and Papulonodules in a 56-Year-Old Woman.

Singer SB, Thomas C, Lezcano C, Robbins M, Gordian A, Nori S, Granter SR, Merola JF, O'Malley JT.

Arthritis Care Res (Hoboken). 2018 Jun;70(6):925-930. doi: 10.1002/acr.23516. Epub 2018 Apr 16. No abstract available.

10.

Intralesional Sodium Thiosulfate Treatment for Calcinosis Cutis in the Setting of Lupus Panniculitis.

Gunasekera NS, Maniar LEG, Lezcano C, Laga AC, Merola JF.

JAMA Dermatol. 2017 Sep 1;153(9):944-945. doi: 10.1001/jamadermatol.2017.0966. No abstract available.

PMID:
28564698
11.

Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.

Lezcano C, Ho J, Seethala RR.

Am J Dermatopathol. 2017 Dec;39(12):896-902. doi: 10.1097/DAD.0000000000000872.

PMID:
28394798
12.

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Font R, Espinas JA, Layos L, Martinez Villacampa M, Capdevila J, Tobeña M, Pisa A, Pericay C, Lezcano C, Fort E, Cardona I, Berga N, Solà J, Borras JM.

Ann Oncol. 2017 Apr 1;28(4):831-835. doi: 10.1093/annonc/mdx006.

13.

Lethal melanoma in children: a clinicopathological study of 12 cases.

Prieto-Granada CN, Lezcano C, Scolyer RA, Mihm MC Jr, Piris A.

Pathology. 2016 Dec;48(7):705-711. doi: 10.1016/j.pathol.2016.08.008. Epub 2016 Oct 27.

PMID:
27956274
14.

Protein side-chain packing problem: is there still room for improvement?

Colbes J, Corona RI, Lezcano C, Rodríguez D, Brizuela CA.

Brief Bioinform. 2017 Nov 1;18(6):1033-1043. doi: 10.1093/bib/bbw079.

PMID:
27567382
15.

Clear Cell Carcinoma of the Penis: An HPV-related Variant of Squamous Cell Carcinoma: A Report of 3 Cases.

Sanchez DF, Rodriguez IM, Piris A, Cañete S, Lezcano C, Velazquez EF, Fernandez-Nestosa MJ, Mendez-Pena JE, Hoang MP, Cubilla AL.

Am J Surg Pathol. 2016 Jul;40(7):917-22. doi: 10.1097/PAS.0000000000000607.

PMID:
26848799
16.

ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.

Kleffel S, Lee N, Lezcano C, Wilson BJ, Sobolewski K, Saab KR, Mueller H, Zhan Q, Posch C, Elco CP, DoRosario A, Garcia SS, Thakuria M, Wang YE, Wang LC, Murphy GF, Frank MH, Schatton T.

J Invest Dermatol. 2016 Apr;136(4):838-846. doi: 10.1016/j.jid.2015.12.038. Epub 2016 Jan 29.

17.

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.

Goldberg JM, Fisher DE, Demetri GD, Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP, George S, Morgan JA, Wagner AJ, Freeman GJ, Ritz J, Lezcano C, Mihm M, Canning C, Hodi FS, Dranoff G.

Clin Cancer Res. 2015 Jul 15;21(14):3178-86. doi: 10.1158/1078-0432.CCR-14-2932. Epub 2015 Mar 24.

18.

Clinicopathological features and histogenesis of penile cysts.

Lezcano C, Chaux A, Velazquez EF, Cubilla AL.

Semin Diagn Pathol. 2015 May;32(3):245-8. doi: 10.1053/j.semdp.2014.12.014. Epub 2014 Dec 27. Review.

PMID:
25701383
19.

HPV- and non-HPV-related subtypes of penile squamous cell carcinoma (SCC): Morphological features and differential diagnosis according to the new WHO classification (2015).

Sanchez DF, Cañete S, Fernández-Nestosa MJ, Lezcano C, Rodríguez I, Barreto J, Alvarado-Cabrero I, Cubilla AL.

Semin Diagn Pathol. 2015 May;32(3):198-221. doi: 10.1053/j.semdp.2014.12.018. Epub 2014 Dec 30.

PMID:
25701382
20.

Nestin depletion induces melanoma matrix metalloproteinases and invasion.

Lee CW, Zhan Q, Lezcano C, Frank MH, Huang J, Larson AR, Lin JY, Wan MT, Lin PI, Ma J, Kleffel S, Schatton T, Lian CG, Murphy GF.

Lab Invest. 2014 Dec;94(12):1382-95. doi: 10.1038/labinvest.2014.130. Epub 2014 Nov 3.

21.

Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells.

Hubbard-Lucey VM, Shono Y, Maurer K, West ML, Singer NV, Ziegler CG, Lezcano C, Motta AC, Schmid K, Levi SM, Murphy GF, Liu C, Winkler JD, Amaravadi RK, Rogler G, Dickinson AM, Holler E, van den Brink MR, Cadwell K.

Immunity. 2014 Oct 16;41(4):579-91. doi: 10.1016/j.immuni.2014.09.011. Epub 2014 Oct 9.

22.

Actinomycotic mastoiditis complicated by sigmoid sinus thrombosis and labyrinthine fistula.

Lezcano C, Simons JP, Colman KL, Cohen MS, Lin PL, Reyes-Múgica M.

Pediatr Dev Pathol. 2014 Nov-Dec;17(6):478-81. doi: 10.2350/14-05-1492-CR.1. Epub 2014 Aug 18.

PMID:
25133452
23.

Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.

Lezcano C, Kleffel S, Lee N, Larson AR, Zhan Q, DoRosario A, Wang LC, Schatton T, Murphy GF.

Lab Invest. 2014 Oct;94(10):1092-102. doi: 10.1038/labinvest.2014.99. Epub 2014 Aug 11.

24.

Adamantinoma-like Ewing sarcoma mimicking basal cell adenocarcinoma of the parotid gland: a case report and review of the literature.

Lezcano C, Clarke MR, Zhang L, Antonescu CR, Seethala RR.

Head Neck Pathol. 2015 Jun;9(2):280-5. doi: 10.1007/s12105-014-0558-0. Epub 2014 Aug 1. Review.

25.

Bevacizumab plus ipilimumab in patients with metastatic melanoma.

Hodi FS, Lawrence D, Lezcano C, Wu X, Zhou J, Sasada T, Zeng W, Giobbie-Hurder A, Atkins MB, Ibrahim N, Friedlander P, Flaherty KT, Murphy GF, Rodig S, Velazquez EF, Mihm MC Jr, Russell S, DiPiro PJ, Yap JT, Ramaiya N, Van den Abbeele AD, Gargano M, McDermott D.

Cancer Immunol Res. 2014 Jul;2(7):632-42. doi: 10.1158/2326-6066.CIR-14-0053. Epub 2014 Apr 21. Erratum in: Cancer Immunol Res. 2014 Sep;2(9):923.

26.

Antitumor granuloma formation by CD4+ T cells in a patient with rapidly progressive melanoma experiencing spiking fevers, neuropathy, and other immune-related toxicity after treatment with ipilimumab.

Luke JJ, Lezcano C, Hodi FS, Murphy GF.

J Clin Oncol. 2015 Feb 20;33(6):e32-5. doi: 10.1200/JCO.2013.49.7735. Epub 2014 Mar 10. No abstract available.

27.

A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Shono Y, Tuckett AZ, Ouk S, Liou HC, Altan-Bonnet G, Tsai JJ, Oyler JE, Smith OM, West ML, Singer NV, Doubrovina E, Pankov D, Undhad CV, Murphy GF, Lezcano C, Liu C, O'Reilly RJ, van den Brink MR, Zakrzewski JL.

Cancer Discov. 2014 May;4(5):578-91. doi: 10.1158/2159-8290.CD-13-0585. Epub 2014 Feb 18.

28.

Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions.

Bankova LG, Lezcano C, Pejler G, Stevens RL, Murphy GF, Austen KF, Gurish MF.

J Immunol. 2014 Mar 15;192(6):2812-20. doi: 10.4049/jimmunol.1301794. Epub 2014 Feb 12.

29.

Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors.

Lezcano C, Lee CW, Larson AR, Menzies AM, Kefford RF, Thompson JF, Mihm MC Jr, Ogino S, Long GV, Scolyer RA, Murphy GF.

Mod Pathol. 2014 Sep;27(9):1193-202. doi: 10.1038/modpathol.2013.226. Epub 2014 Jan 17.

30.

Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.

Larson AR, Dresser KA, Zhan Q, Lezcano C, Woda BA, Yosufi B, Thompson JF, Scolyer RA, Mihm MC Jr, Shi YG, Murphy GF, Lian CG.

Mod Pathol. 2014 Jul;27(7):936-44. doi: 10.1038/modpathol.2013.224. Epub 2014 Jan 3.

31.

Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Larson AR, Lee CW, Lezcano C, Zhan Q, Huang J, Fischer AH, Murphy GF.

Am J Pathol. 2014 Jan;184(1):71-8. doi: 10.1016/j.ajpath.2013.09.020.

32.

The multidrug-resistance transporter ABCB5 is expressed in human placenta.

Volpicelli ER, Lezcano C, Zhan Q, Girouard SD, Kindelberger DW, Frank MH, Frank NY, Crum CP, Murphy GF.

Int J Gynecol Pathol. 2014 Jan;33(1):45-51. doi: 10.1097/PGP.0b013e31829c677f.

33.

PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD.

Ghosh A, Holland AM, Dogan Y, Yim NL, Rao UK, Young LF, West ML, Singer NV, Lee H, Na IK, Tsai JJ, Jenq RR, Penack O, Hanash AM, Lezcano C, Murphy GF, Liu C, Sadelain M, Sauer MG, Sant'angelo D, van den Brink MR.

Cancer Res. 2013 Aug 1;73(15):4687-96. doi: 10.1158/0008-5472.CAN-12-4699. Epub 2013 Jun 3.

34.

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity.

Ghosh A, Dogan Y, Moroz M, Holland AM, Yim NL, Rao UK, Young LF, Tannenbaum D, Masih D, Velardi E, Tsai JJ, Jenq RR, Penack O, Hanash AM, Smith OM, Piersanti K, Lezcano C, Murphy GF, Liu C, Palomba ML, Sauer MG, Sadelain M, Ponomarev V, van den Brink MR.

J Clin Invest. 2013 Jun;123(6):2654-62. doi: 10.1172/JCI66301. Epub 2013 May 15.

35.

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, Lizée G, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA.

Clin Cancer Res. 2013 Mar 1;19(5):1225-31. doi: 10.1158/1078-0432.CCR-12-1630. Epub 2013 Jan 10.

36.

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC Jr, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG.

Cell. 2012 Sep 14;150(6):1135-46. doi: 10.1016/j.cell.2012.07.033.

37.

Cutaneous gnathostomiasis: report of 6 cases with emphasis on histopathological demonstration of the larva.

Laga AC, Lezcano C, Ramos C, Costa H, Chian C, Salinas C, Salomon M, del Solar M, Bravo F.

J Am Acad Dermatol. 2013 Feb;68(2):301-5. doi: 10.1016/j.jaad.2012.07.016. Epub 2012 Aug 30.

PMID:
22940406
38.

Local injection of infliximab in symptomatic isolated mucosal lesions: a novel scenario for endoscopic therapy?

Lorenzo-Zúñiga V, Boix J, Mañosa M, Lezcano C, Cabré E, Moreno de Vega V, Domènech E.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E59-61. doi: 10.1002/ibd.23018. No abstract available.

PMID:
22605623
39.

Graft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cells.

Zhan Q, Korngold R, Lezcano C, McKeon F, Murphy GF.

Biol Blood Marrow Transplant. 2012 Jun;18(6):841-51. doi: 10.1016/j.bbmt.2012.02.004. Epub 2012 Mar 30.

40.

Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological study of 139 lesions in 121 patients.

Chaux A, Velazquez EF, Amin A, Soskin A, Pfannl R, Rodríguez IM, Barreto JE, Lezcano C, Ayala G, Netto GJ, Cubilla AL.

Hum Pathol. 2012 Jul;43(7):1020-7. doi: 10.1016/j.humpath.2011.07.025. Epub 2011 Dec 12.

PMID:
22169255
41.

Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.

Chaux A, Pfannl R, Rodríguez IM, Barreto JE, Velazquez EF, Lezcano C, Piris A, Netto GJ, Cubilla AL.

Am J Surg Pathol. 2011 Apr;35(4):553-62. doi: 10.1097/PAS.0b013e3182113402.

PMID:
21399489
42.

Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature.

Chaux A, Pfannl R, Lloveras B, Alejo M, Clavero O, Lezcano C, Muñoz N, de Sanjosé S, Bosch X, Hernández-Pérez M, Velazquez EF, Cubilla AL.

Am J Surg Pathol. 2010 Mar;34(3):385-92. doi: 10.1097/PAS.0b013e3181cdad23.

PMID:
20139761
43.

Papillary squamous cell carcinoma, not otherwise specified (NOS) of the penis: clinicopathologic features, differential diagnosis, and outcome of 35 cases.

Chaux A, Soares F, Rodríguez I, Barreto J, Lezcano C, Torres J, Velazquez EF, Cubilla AL.

Am J Surg Pathol. 2010 Feb;34(2):223-30. doi: 10.1097/PAS.0b013e3181c7666e.

PMID:
20061934
44.

The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay.

Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Velazquez EF, Lezcano C, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Muñoz N, Quint W, de Sanjose S, Bosch FX.

Am J Surg Pathol. 2010 Jan;34(1):104-14. doi: 10.1097/PAS.0b013e3181c76a49.

PMID:
20035150
45.

Comparison of subtypes of penile squamous cell carcinoma from high and low incidence geographical regions.

Chaux A, Lezcano C, Cubilla AL, Tamboli P, Ro J, Ayala A.

Int J Surg Pathol. 2010 Aug;18(4):268-77. doi: 10.1177/1066896909339184. Epub 2009 Jul 3.

PMID:
19578046
46.

Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.

Chaux A, Reuter V, Lezcano C, Velazquez EF, Torres J, Cubilla AL.

Am J Surg Pathol. 2009 Sep;33(9):1299-306. doi: 10.1097/PAS.0b013e3181a418ae.

PMID:
19471153
47.

Autopsy findings in 14 patients with penile squamous cell carcinoma.

Chaux A, Reuter V, Lezcano C, Velazquez E, Codas R, Cubilla AL.

Int J Surg Pathol. 2011 Apr;19(2):164-9. doi: 10.1177/1066896909333781. Epub 2009 May 1.

PMID:
19411278
48.

Active electroreception in Gymnotus omari: imaging, object discrimination, and early processing of actively generated signals.

Caputi AA, Castelló ME, Aguilera PA, Pereira C, Nogueira J, Rodríguez-Cattaneo A, Lezcano C.

J Physiol Paris. 2008 Jul-Nov;102(4-6):256-71. doi: 10.1016/j.jphysparis.2008.10.005. Epub 2008 Oct 17. Review.

PMID:
18992336

Supplemental Content

Loading ...
Support Center